2019
DOI: 10.3390/ijms20102523
|View full text |Cite
|
Sign up to set email alerts
|

Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs)

Abstract: Adipose tissue is now on the top one of stem cell sources regarding its accessibility, abundance, and less painful collection procedure when compared to other sources. The adipose derived stem cells (ADSCs) that it contains can be maintained and expanded in culture for long periods of time without losing their differentiation capacity, leading to large cell quantities being increasingly used in cell therapy purposes. Many reports showed that ADSCs-based cell therapy products demonstrated optimal efficacy and e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
225
0
7

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 314 publications
(232 citation statements)
references
References 248 publications
(234 reference statements)
0
225
0
7
Order By: Relevance
“…Human adipose-derived stem cells (ADSCs) are a common type of mesenchymal stem cell (MSC) and have been mainly used in regenerative medicine for treating various diseases [1][2][3][4][5][6] including osteoarthritis, degenerative arthritis, cartilage or tendon injury, graft-versus-host diseases, chronic kidney diseases, etc. Currently, ADSCs are among the mostly used stem cell sources in the cell transplantation field [7][8][9][10][11] .…”
Section: Introductionmentioning
confidence: 99%
“…Human adipose-derived stem cells (ADSCs) are a common type of mesenchymal stem cell (MSC) and have been mainly used in regenerative medicine for treating various diseases [1][2][3][4][5][6] including osteoarthritis, degenerative arthritis, cartilage or tendon injury, graft-versus-host diseases, chronic kidney diseases, etc. Currently, ADSCs are among the mostly used stem cell sources in the cell transplantation field [7][8][9][10][11] .…”
Section: Introductionmentioning
confidence: 99%
“…The collection procedure of bone marrow is painful and provides a limited amount of multipotent cells [41][42][43], however, the second collection procedure has gained more and more attention. SVF is the heterogeneous mixture, which contains many types of cells: fibroblasts, endothelial cells, adipocytes, blood cells, as well as adipose-derived mesenchymal stem cells (ADSCs)) [36,[44][45][46]. The latter ones expand easily in the cell culture and age slowly, having a multipotent differentiation capacity comparable to that of bone marrow stem cells [32,36,[47][48][49][50].…”
Section: Introductionmentioning
confidence: 99%
“…Various sources of MSCs include: bone marrow [3], adipose tissue [4], umbilical cord [5], dental pulp [6], and other tissues [7]. Due to their early developmental stage, wide differentiation capacity, various mechanisms of action, and relatively easy propagation ex vivo, MSCs, including UC-MSCs and ADSCs, represent cell populations with great potential for wide use in cellular-based therapies [8,9]. MSCs have been already successfully used in several clinical applications (see: clinicaltrial.gov database) and their beneficial effects were predominantly related to their paracrine activity [10].…”
Section: Introductionmentioning
confidence: 99%